Spyre Therapeutics Inc (SYRE)

Working Capital Ratio

94.60%

Quarterly · Period ending:

SYRE logo

SYRE Working Capital Ratio

Latest reported94.60%
SYRE Quarterly Working Capital Ratio (57.06% → 94.60%)
High-resolution chart · PNG

SYRE working capital ratio history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Spyre Therapeutics Inc Working Capital Ratio — Quarterly
Period endingWorking Capital Ratio
94.6034%
88.8525%
92.4548%
90.8296%
84.5854%
87.5938%
91.114%
86.3333%
94.851%
91.1512%
90.549%
77.7155%
3.1421%
60.5075%
66.9094%
70.4858%
75.7064%
67.6903%
71.6364%
75.2249%
77.4%
72.7578%
82.5069%
83.563%
84.4226%
57.3116%
67.497%
77.1599%
82.4859%
89.4903%
85.4552%
88.201%
91.2185%
86.5263%
88.0254%
90.3144%
92.0186%
91.9712%
93.1348%
94.1452%
95.1411%
88.2987%
92.5208%
93.3639%
93.4972%
96.7463%
57.0648%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.